Results 41 to 50 of about 86,105 (313)

Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family

Emerging Infectious Diseases, 2002
Consecutive patient cultures (140) of Mycobacteriium tuberculosis were collected from five Russian civilian and prison tuberculosis laboratories and analyzed for rifampin (rpoB) and isoniazid resistance (inhA, katG, ahpC); transmission of Beijing family ...
Francis Drobniewski, Yanina Balabanova, Michael Ruddy, Laura Weldon, Katya Jeltkova, Timothy Brown, Nadezdna Malomanova, Elvira Elizarova, Alexander Melentyey, Ebgeny Mutovkin, Svetlana Zhakharova, Ivan Fedorin   +11 more
doaj   +1 more source

Adjunctive rifampin for the treatment of Staphylococcus aureus bacteremia with deep infections: A meta-analysis.

PLoS ONE, 2020
BACKGROUND:Staphylococcus aureus (S. aureus) bacteremia (SAB) has high morbidity and mortality, with the development of methicillin-resistant S. aureus (MRSA) and the recognized shortcomings of vancomycin, its management is becoming more complicated ...
Huan Ma, Jie Cheng, Lengyue Peng, Yawen Gao, Guangli Zhang, Zhengxiu Luo   +5 more
doaj   +1 more source

A literature review of liver function test elevations in rifampin drug–drug interaction studies

Clinical and Translational Science, 2022
Although rifampin drug–drug interaction (DDI) studies are routinely conducted, there have been instances of liver function test (LFT) elevations, warranting further evaluation.
Sherry M. Ibrahim, Yazdi K. Pithavala, Manoli Vourvahis, Joseph Chen   +3 more
doaj   +1 more source

Efficacy of ceftaroline and rifampin, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteomyelitis without implant

Microbiology Spectrum, 2023
The in vivo efficacy of ceftaroline and rifampin alone or in combination was investigated in an experimental rat model of methicillin-resistant Staphylococcus epidermidis (MRSE) osteomyelitis.
S. Albac, N. Anzala, D. Bonnot, H. Mirfendereski, P. Chavanet, D. Croisier   +5 more
doaj   +1 more source

Effect of the nanoliposomal formulations of rifampin and N-acetyl cysteine on staphylococcus epidermidis biofilm [PDF]

Nanomedicine Journal, 2020
Objective(s): Staphylococcus epidermidis is a common cause of medical device-associated infections due to biofilm formation, and its elimination is extremely challenging. Although rifampin efficacy against S.
Farzaneh Bazrgari, Bahman Khameneh, Bibi Sedigheh Fazly Bazzaz, Asma Mahmoudi, Bizhan Malaekeh-Nikouei   +4 more
doaj   +1 more source

Is rifampin use associated with better outcome in staphylococcal prosthetic valve endocarditis? A multicenter retrospective study.

Clinical Infectious Diseases, 2020
BACKGROUND International guidelines recommend rifampin-based combinations for staphylococcal prosthetic valve endocarditis (PVE). However, no robust clinical data supports this recommendation, and rifampin tolerability is an issue.
A. Le Bot, R. Lecomte, P. Gazeau, F. Bénézit, C. Arvieux, S. Ansart, D. Boutoille, R. Le Berre, C. Chabanne, Matthieu Lesouhaitier, L. Dejoies, E. Flécher, J. Chapplain, P. Tattevin, M. Revest   +14 more
semanticscholar   +1 more source

Susceptibility of Mycobacteria to Rifampin [PDF]

Antimicrobial Agents and Chemotherapy, 1972
The Mycobacterium species M. tuberculosis, M. avium-intracellulare, M. kansasii, M. marinum, M. scrofulaceum, M. fortuitum, M. terrae , and M. gordonae were analyzed for their susceptibility to rifampin. M. tuberculosis, M. kansasii , and
Hugo L. David, James O. Kilburn, Vella A. Silcox, Charles L. Woodley   +3 more
openaire   +3 more sources

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

New England Journal of Medicine, 2018
BACKGROUND A 9‐month regimen of isoniazid can prevent active tuberculosis in persons with latent tuberculosis infection. However, the regimen has been associated with poor adherence rates and with toxic effects.
D. Menzies, M. Adjobimey, R. Ruslami, A. Trajman, O. Sow, H. Kim, J. Baah, G. Marks, R. Long, V. Hoeppner, K. Elwood, H. Al-Jahdali, M. Gninafon, L. Apriani, R. C. Koesoemadinata, A. Kritski, V. Rolla, B. Bah, A. Camara, I. Boakye, V. Cook, H. Goldberg, C. Valiquette, K. Hornby, M. Dion, P. Li, P. Hill, K. Schwartzman, A. Benedetti   +28 more
semanticscholar   +1 more source

Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France. [PDF]

, 2013
We compare the whole-genome sequences of two multidrug-resistant clinical Acinetobacter baumannii isolates recovered in the same patient before (ABIsac_ColiS susceptible to colistin and rifampin only) and after (ABIsac_ColiR resistant to colistin and ...
C. Robert, D. Raoult, G. Gimenez, J.M. Rolain, M. Kempf, S.M. Diene   +5 more
core   +4 more sources

Influence of Rifampin Therapy on Serum Bactericidal Activity in the Presence of Cloxacillin and Vancomycin

Canadian Journal of Infectious Diseases, 1990
In this study the effect of rifampin on serum inhibitory and serum bactericidal titres was examined. Sera were prepared from pooled human serum to contain vancomycin (10 mg/L), cloxacillin (5 mg/L) or rifampin (1 mg/L), and the combinations cloxacillin ...
Andrew MR Mackenzie, Noni E MacDonald
doaj   +1 more source